Instituto Rosenbusch S.A. Total Liabilities
Instituto Rosenbusch S.A. total liabilities. Based on the latest financial reports, Instituto Rosenbusch S.A. (ROSE) has total liabilities worth AR$8.27 Billion ARS (≈ $5.99 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Instituto Rosenbusch S.A. defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Instituto Rosenbusch S.A. (2000–2025)
Total liabilities of Instituto Rosenbusch S.A. from 2000 to 2025. This chart illustrates how Instituto Rosenbusch S.A.'s total liabilities have evolved over time, based on quarterly financial data. Check Instituto Rosenbusch S.A. (ROSE) asset resilience to evaluate the company's liquid asset resilience ratio.
Instituto Rosenbusch S.A. Competitors by Total Liabilities
The table below lists competitors of Instituto Rosenbusch S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sungshin Cement Co Ltd
KO:004985
|
Korea | ₩762.60 Billion |
|
Bang Overseas Limited
NSE:BANG
|
India | Rs1.03 Billion |
|
Traka Resources Ltd
AU:TKL
|
Australia | AU$184.14K |
|
Brüder Mannesmann Aktiengesellschaft
F:BMM
|
Germany | €49.16 Million |
|
Invibes Advertising NV
PA:ALINV
|
France | €9.63 Million |
|
CASI Pharmaceuticals Inc
NASDAQ:CASI
|
USA | $53.05 Million |
|
Openlearning Ltd
AU:OLL
|
Australia | AU$5.43 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Instituto Rosenbusch S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Instituto Rosenbusch S.A. (ROSE) total assets.
Liquidity & Leverage Metrics
Instituto Rosenbusch S.A. Total Liabilities Ratios Explained
Instituto Rosenbusch S.A. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -10.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Instituto Rosenbusch S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Instituto Rosenbusch S.A. (2000–2025)
The table below shows the annual total liabilities of Instituto Rosenbusch S.A. from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | AR$8.27 Billion ≈ $5.99 Million |
+39.46% |
| 2024-12-31 | AR$5.93 Billion ≈ $4.29 Million |
-7.81% |
| 2023-12-31 | AR$6.43 Billion ≈ $4.66 Million |
+579.03% |
| 2022-12-31 | AR$947.48 Million ≈ $685.60K |
+72.86% |
| 2021-12-31 | AR$548.10 Million ≈ $396.61K |
+3.82% |
| 2020-12-31 | AR$527.95 Million ≈ $382.02K |
+38.42% |
| 2019-12-31 | AR$381.42 Million ≈ $276.00K |
+72.74% |
| 2018-12-31 | AR$220.81 Million ≈ $159.78K |
+73.94% |
| 2017-12-31 | AR$126.95 Million ≈ $91.86K |
+10.75% |
| 2016-12-31 | AR$114.62 Million ≈ $82.94K |
+19.96% |
| 2015-12-31 | AR$95.55 Million ≈ $69.14K |
+31.77% |
| 2014-12-31 | AR$72.51 Million ≈ $52.47K |
+6.26% |
| 2013-12-31 | AR$68.24 Million ≈ $49.38K |
+39.21% |
| 2012-12-31 | AR$49.02 Million ≈ $35.47K |
+59.78% |
| 2011-12-31 | AR$30.68 Million ≈ $22.20K |
+32.08% |
| 2010-12-31 | AR$23.23 Million ≈ $16.81K |
+32.45% |
| 2009-12-31 | AR$17.54 Million ≈ $12.69K |
+48.67% |
| 2008-12-31 | AR$11.80 Million ≈ $8.54K |
-27.78% |
| 2007-12-31 | AR$16.33 Million ≈ $11.82K |
+30.13% |
| 2006-12-31 | AR$12.55 Million ≈ $9.08K |
+9.78% |
| 2005-12-31 | AR$11.43 Million ≈ $8.27K |
+31.30% |
| 2004-12-31 | AR$8.71 Million ≈ $6.30K |
+18.78% |
| 2003-12-31 | AR$7.33 Million ≈ $5.30K |
+36.09% |
| 2002-12-31 | AR$5.39 Million ≈ $3.90K |
+96.10% |
| 2001-12-31 | AR$2.75 Million ≈ $1.99K |
-2.31% |
| 2000-12-31 | AR$2.81 Million ≈ $2.03K |
-- |
About Instituto Rosenbusch S.A.
Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious kera… Read more